Singular Genomics Systems
Singular Genomics Systems is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.
About Singular Genomics Systems
Singular Genomics Systems is a startup founded in 2017 based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Singular Genomics Systems develops the G4X Spatial Sequencing Platform, a high-throughput spatial multiomics technology that enables transcriptomic, proteomic, and histological analysis from formalin-fixed paraffin-embedded (FFPE) tissue at subcellular resolution for research and precision diagnostics.
Explore Singular Genomics Systems's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.